Published articles

Published articles 1 records found  Search took 0.01 seconds. 
9 p, 847.0 KB Is there a justification for classifying GLP-1 receptor agonists as basal and prandial? / Miñambres, Inka (Institut d'Investigació Biomèdica Sant Pau) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Several GLP-1 receptor agonists are currently available for treatment of type 2 diabetic patients. Based on their pharmacokinetic/pharmacodynamic profile, these drugs are classified as short-acting GLP-1 receptor agonists (exenatide and lixisenatide) or long-acting GLP-1 receptor agonists (exenatide-LAR, liraglutide, albiglutide, and dulaglutide). [...]
2017 - 10.1186/s13098-017-0204-6
Diabetology & Metabolic Syndrome, Vol. 9 (january 2017)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.